4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-17-065244
CFO and Treasurer acquired 500,000 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Krognes Steve E. CFO and Treasurer | 2017-12-12 | Conversion | +500,000 | 1,000,000 | I | ||
| Derivatives | |||||||
| Krognes Steve E. CFO and Treasurer | 2017-12-12 | Conversion · Series A-1 Preferred Stock | −500,000 | 0 | I | ||
Loading xslF345X03/doc4.xml…